Efficacy and safety of acitretin monotherapy in children with pustular psoriasis: results from 15 cases and a literature review

Background: There is a few evidence-based information regarding the efficacy and safety of acitretin treatment in children with pustular psoriasis (PP). Objective: This study aimed to provide an additional evidence for this field. Methods: A retrospective study was undertaken for 15 children with PP...

Full description

Bibliographic Details
Main Authors: Pingjiao Chen, Changxing Li, Rujun Xue, Huiheng Chen, Xin Tian, Kang Zeng, Xibao Zhang, Jingyao Liang
Format: Article
Language:English
Published: Taylor & Francis Group 2018-05-01
Series:Journal of Dermatological Treatment
Subjects:
Online Access:http://dx.doi.org/10.1080/09546634.2017.1395798
_version_ 1797683729305436160
author Pingjiao Chen
Changxing Li
Rujun Xue
Huiheng Chen
Xin Tian
Kang Zeng
Xibao Zhang
Jingyao Liang
author_facet Pingjiao Chen
Changxing Li
Rujun Xue
Huiheng Chen
Xin Tian
Kang Zeng
Xibao Zhang
Jingyao Liang
author_sort Pingjiao Chen
collection DOAJ
description Background: There is a few evidence-based information regarding the efficacy and safety of acitretin treatment in children with pustular psoriasis (PP). Objective: This study aimed to provide an additional evidence for this field. Methods: A retrospective study was undertaken for 15 children with PP who received acitretin in doses of 0.6–1.0 mg/kg/day for 4–6 weeks, the transition dose of 0.2–0.4 mg/kg/day for 4–6 weeks and maintenance dose of 0.2–0.3 mg/kg/day. Additionally, a literature review on this topic is conducted. Results: Of 15 children with generalized PP (GPP, n = 10), palmoplantar psoriasis (PPP, n = 3), and acrodermatitis continua of Hallopeau (ACH, n = 2), 93.3% (14/15) showed good response, only one case with ACH exhibited moderate response. During the 10–32 months of follow-up, acitrerin monotherapy for children cases with PP overall showed good efficacy and safety. In the literature review, a total of 107 childhood PP cases treated with acitretin in 21 studies were included in the analysis. The clinical effectiveness was obtained in 88.8% (95/107) patients treated with acitretin as monotherapy or combination therapy, and most of cases (92.6%, 100/107) treated by acitretin did not report side effects during the treatment and follow-up of acitretin. Limitation: This study is just included a small sample sizes and no standardized studies were used in the literature. Conclusion: Acitretin therapy for children with PP (monotherapy or combination therapy), all showed a satisfactory therapeutic effect and safety, independent of the short or long-tern therapeutic procedures.
first_indexed 2024-03-12T00:18:59Z
format Article
id doaj.art-37e699a318984ab4be1c53efbe388396
institution Directory Open Access Journal
issn 0954-6634
1471-1753
language English
last_indexed 2024-03-12T00:18:59Z
publishDate 2018-05-01
publisher Taylor & Francis Group
record_format Article
series Journal of Dermatological Treatment
spelling doaj.art-37e699a318984ab4be1c53efbe3883962023-09-15T14:08:31ZengTaylor & Francis GroupJournal of Dermatological Treatment0954-66341471-17532018-05-0129435336310.1080/09546634.2017.13957981395798Efficacy and safety of acitretin monotherapy in children with pustular psoriasis: results from 15 cases and a literature reviewPingjiao Chen0Changxing Li1Rujun Xue2Huiheng Chen3Xin Tian4Kang Zeng5Xibao Zhang6Jingyao Liang7Nanfang Hospital, Southern Medical UniversityDongguan Sixth People’s HospitalGuangzhou Medical UniversityGuangzhou Medical UniversityGuangzhou Medical UniversityNanfang Hospital, Southern Medical UniversityGuangzhou Medical UniversityGuangzhou Medical UniversityBackground: There is a few evidence-based information regarding the efficacy and safety of acitretin treatment in children with pustular psoriasis (PP). Objective: This study aimed to provide an additional evidence for this field. Methods: A retrospective study was undertaken for 15 children with PP who received acitretin in doses of 0.6–1.0 mg/kg/day for 4–6 weeks, the transition dose of 0.2–0.4 mg/kg/day for 4–6 weeks and maintenance dose of 0.2–0.3 mg/kg/day. Additionally, a literature review on this topic is conducted. Results: Of 15 children with generalized PP (GPP, n = 10), palmoplantar psoriasis (PPP, n = 3), and acrodermatitis continua of Hallopeau (ACH, n = 2), 93.3% (14/15) showed good response, only one case with ACH exhibited moderate response. During the 10–32 months of follow-up, acitrerin monotherapy for children cases with PP overall showed good efficacy and safety. In the literature review, a total of 107 childhood PP cases treated with acitretin in 21 studies were included in the analysis. The clinical effectiveness was obtained in 88.8% (95/107) patients treated with acitretin as monotherapy or combination therapy, and most of cases (92.6%, 100/107) treated by acitretin did not report side effects during the treatment and follow-up of acitretin. Limitation: This study is just included a small sample sizes and no standardized studies were used in the literature. Conclusion: Acitretin therapy for children with PP (monotherapy or combination therapy), all showed a satisfactory therapeutic effect and safety, independent of the short or long-tern therapeutic procedures.http://dx.doi.org/10.1080/09546634.2017.1395798pustular psoriasisgeneralized pustular psoriasispalmoplantar psoriasisacitretinchildrentreatment
spellingShingle Pingjiao Chen
Changxing Li
Rujun Xue
Huiheng Chen
Xin Tian
Kang Zeng
Xibao Zhang
Jingyao Liang
Efficacy and safety of acitretin monotherapy in children with pustular psoriasis: results from 15 cases and a literature review
Journal of Dermatological Treatment
pustular psoriasis
generalized pustular psoriasis
palmoplantar psoriasis
acitretin
children
treatment
title Efficacy and safety of acitretin monotherapy in children with pustular psoriasis: results from 15 cases and a literature review
title_full Efficacy and safety of acitretin monotherapy in children with pustular psoriasis: results from 15 cases and a literature review
title_fullStr Efficacy and safety of acitretin monotherapy in children with pustular psoriasis: results from 15 cases and a literature review
title_full_unstemmed Efficacy and safety of acitretin monotherapy in children with pustular psoriasis: results from 15 cases and a literature review
title_short Efficacy and safety of acitretin monotherapy in children with pustular psoriasis: results from 15 cases and a literature review
title_sort efficacy and safety of acitretin monotherapy in children with pustular psoriasis results from 15 cases and a literature review
topic pustular psoriasis
generalized pustular psoriasis
palmoplantar psoriasis
acitretin
children
treatment
url http://dx.doi.org/10.1080/09546634.2017.1395798
work_keys_str_mv AT pingjiaochen efficacyandsafetyofacitretinmonotherapyinchildrenwithpustularpsoriasisresultsfrom15casesandaliteraturereview
AT changxingli efficacyandsafetyofacitretinmonotherapyinchildrenwithpustularpsoriasisresultsfrom15casesandaliteraturereview
AT rujunxue efficacyandsafetyofacitretinmonotherapyinchildrenwithpustularpsoriasisresultsfrom15casesandaliteraturereview
AT huihengchen efficacyandsafetyofacitretinmonotherapyinchildrenwithpustularpsoriasisresultsfrom15casesandaliteraturereview
AT xintian efficacyandsafetyofacitretinmonotherapyinchildrenwithpustularpsoriasisresultsfrom15casesandaliteraturereview
AT kangzeng efficacyandsafetyofacitretinmonotherapyinchildrenwithpustularpsoriasisresultsfrom15casesandaliteraturereview
AT xibaozhang efficacyandsafetyofacitretinmonotherapyinchildrenwithpustularpsoriasisresultsfrom15casesandaliteraturereview
AT jingyaoliang efficacyandsafetyofacitretinmonotherapyinchildrenwithpustularpsoriasisresultsfrom15casesandaliteraturereview